Assessment of type I interferon response in routine practice in France in 2022

An European Alliance of Associations for Rheumatology task force recently recommended specific points to consider for exploring type I interferon pathway in patients, highlighting the lack of analytical assays validated for clinical routine. We report here the French experience on a type I interfero...

Descripción completa

Detalles Bibliográficos
Autores principales: Nombel, Anais, Foray, Anne Perrine, Garnier, Lorna, Lombard, Christine, Hachulla, Eric, Bader-Meunier, Brigitte, Georgin-Lavialle, Sophie, Melki, Isabelle, Walzer, Thierry, Belot, Alexandre, Viel, Sebastien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Miscellaneous
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277519/
https://www.ncbi.nlm.nih.gov/pubmed/37321666
http://dx.doi.org/10.1136/rmdopen-2023-003211
Descripción
Sumario:An European Alliance of Associations for Rheumatology task force recently recommended specific points to consider for exploring type I interferon pathway in patients, highlighting the lack of analytical assays validated for clinical routine. We report here the French experience on a type I interferon pathway assay that has been set up and used routinely since 2018 in Lyon, France.

Ejemplares similares